240 Per Cent Returns: Multibagger Auto Component Manufacturer Reports Strong Q4 Results; PAT Jumps 13 Per Cent 240 Per Cent Returns: Multibagger Auto Component Manufacturer Reports Strong Q4 Results; PAT Jumps 13 Per Cent Company's revenue surged 14 per cent YoY to Rs 2,136.06 crore, up from Rs 1,874.55 crore in the same quarter last year. Manoj Reddy Sama / Friday, February 28, 2025 0 295 Article rating: 2.0 The EBITDA rose 14 per cent YoY to Rs 370.4 crore, compared to Rs 324.1 crore in Q4 CY23. Read more
Smallcap Company Reports 157 Per Cent EBITDA Growth Despite Revenue Decline Smallcap Company Reports 157 Per Cent EBITDA Growth Despite Revenue Decline The company’s revenue declined 10 per cent year-on-year (YoY) to Rs 3,675.7 crore, compared to Rs 4,100.6 crore in Q4 CY23. Manoj Reddy Sama / Friday, February 28, 2025 0 325 Article rating: 4.2 Company is a leading vertically integrated manufacturer of carbon, cement, and advanced materials. Read more
From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why! Mandar Wagh / Friday, February 28, 2025 0 217 Article rating: 5.0 After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why! Read more
350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent 350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent Net profit witnessed a 33 per cent YoY increase, reaching Rs 73.1 crore, compared to Rs 54.9 crore in Q4 CY23. Manoj Reddy Sama / Friday, February 28, 2025 0 447 Article rating: 4.1 Over the last five years, the stock has delivered an impressive return of 352.55 per cent. The company’s current market capitalization stands at Rs 10,603 crore. Read more
Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment. Abhishek Wani / Friday, February 28, 2025 0 82 Article rating: 4.3 With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment. Read more